Aug. 5 at 9:22 PM
$NTR Got the full official release. Here's the fuller picture on Nutrien's Q2 2026:
**Headline numbers**
- Revenue:
$10.81B (vs
$10.44B a year ago, beat estimates)
- Net earnings:
$1.22B, or
$2.53/diluted share (down slightly from
$1.229B /
$2.50 a year ago)
- Adjusted EBITDA:
$2.43B (down 2% YoY)
- Adjusted EPS:
$2.61 (down from
$2.65 a year ago, missed the
$2.72 consensus)
**By segment (vs. year-ago quarter)**
- **Potash**: Adjusted EBITDA up 30% to
$658M — record first-half sales volumes, higher global prices, cost discipline (controllable cash cost still under
$60/tonne)
- **Nitrogen**: Adjusted EBITDA down 5% to
$635M — lower sales volumes (no production from Trinidad/New Madrid, which are shutting down) partly offset by higher prices
- **Retail**: Adjusted EBITDA down 2% to
$1.13B — lower crop nutrient volumes and higher fuel costs
- **Phosphate**: Adjusted EBITDA down 75% to
$23M — hit hard by higher sulfur input costs, essentially the weak link this quarter
L
